REG - ConvaTec Group PLC - Director Declaration

ConvaTecAnnouncement

03/05/2018 10:40

2018-05-03T09:39:11.566Zreuters.comtag:reuters.com,2018-05-03:newsml_RSC0252Na:13TXT
This file is provided for EAP sample purposes only; it's structure and detail are subject to change, and should not be used as a definitive reference for actual development and processing.2018-05-03T09:39:11.566Z2018-05-03T09:39:11.566Z____UCDP:parsn_lse_10.54.4.69_1.2.37235:2019-06-03T09:39:11.566Z3RSC0252NaREG - ConvaTec Group PLC  - Director DeclarationHealthcare (TRBC level 1)Pharmaceuticals & Medical Research (TRBC level 2)LEGACY: Pharmaceuticals (TRBC level 3)LEGACY: Generic & Specialty Pharmaceuticals (TRBC)Proprietary & Advanced Pharmaceuticals (TRBC level 5)Pharmaceuticals (TRBC level 4)Western EuropeUnited KingdomEuropeSuggested SourcesNews AnnouncementsRegulatory Corporate News AnnouncementsCompany NewsEurope daily earnings hits & missesConvaTec Group PLC








RNS Number : 0252N
ConvaTec Group PLC
03 May 2018
 

ConvaTec Director Declaration
Reading, United Kingdom (3 May 2018)
ConvaTec Group Plc ("ConvaTec" or "the Company") announces that Dr Ros Rivaz, an Independent Non-Executive Director of the Company, has been appointed as an Independent Non-Executive Director of CEVA Logistics AG, with effect from today.
After an initial public offering, it is anticipated that CEVA's registered shares will be listed on the SIX Swiss Exchange with effect from 4 May 2018.
This announcement is made in accordance with Listing Rule 9.6.14R.
 
Enquiries
Media
Bobby Leach, VP Group Corporate Affairs, ConvaTec                    +44 (0)7770 842 226
Alastair Elwen, Finsbury                                                             +44 (0)207 251 3801
Analysts and Investors
John Crosse, VP Investor Relations, ConvaTec                             +44 (0)7500 141 435
Kirsty Law, Director Investor Relations, ConvaTec                         +44 (0)7470 909 582
investorrelations@convatec.com
 ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92
About ConvaTec
ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. ConvaTec's products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com where a copy of this announcement can also be found.
 
 



This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDNUGUAWAUPRUBW